ARCHIVES

“What Is Good For NCI Is Good For NIH,” Broder Says In Address

This article is from The Cancer Letter archive.

Vol. 21 No. 02 | January 13, 1995

Download PDF Visit The Full Archive

Related Articles

FDA Breakthrough Designation Granted to Pfizer’s Palbociclib

April 26, 2013

DCT Advisors Reject MRS Concept, Approve RDOG Expansion

November 30, 1990

Chemopreventive Phase I, Preclinical Studies Concept Approved

May 13, 1983

Construction, Pay Raise, Foundation Bills Clear Senate Committee

December 1, 1989

NCI Programs: Institute Seeks White Papers On Technology

September 11, 1998

Isis 3521 Gets Fast-track Status For FDA Review.

December 1, 2000